Developer docs
API playgroundTry for free, no card

Search company profiles

Vitls

Full company profile

uuid0006vvp

Namestring
Vitls
Legal namestring
Vitls Inc.
Websiteurl
vitlsinc.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Vitls is a Houston-based healthcare technology company that develops an FDA 510(k)-cleared continuous vital signs monitoring platform for clinical and home use. Founded in 2016 by Werner Vorster after his son suffered from febrile seizures, the company relocated from South Africa to Texas to access the U.S. healthcare market and the Texas Medical Center innovation ecosystem. The platform combines a disposable, thin, flexible, waterproof wearable device (Tégo) with a 5-day battery life, a HIPAA-compliant cloud backend (Vitls Cloud), and mobile/web applications (Vitls App and Dashboard) that stream continuous vital signs — including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement/fall detection — to clinicians and EHR systems.

The company targets hospitals and healthcare systems (post-operative monitoring, general floor surveillance outside the ICU), emergency departments (rapid triage), pharmaceutical companies and CROs (remote monitoring of clinical trial participants), and pediatric patients aged two and older as a differentiated use case. Its go-to-market is direct enterprise field sales to hospitals, supplemented by channel signals through accelerator and competition programs (TMCx, Dreamit Ventures, KidsX, NCC-PDI). Pricing is quote-based and not publicly disclosed.

Vitls generates revenue through two streams: sales of disposable Tégo wearable devices (hardware) and subscription/usage-based access to the Vitls Cloud platform (recurring SaaS-style). Revenue and customer count are not disclosed; the company reports only five or more healthcare-provider pilots in Houston, Philadelphia, and New York, including an IRB-approved study with Texas Children's Hospital and a trial invitation at a 30-bed oncology unit. The company has raised approximately $100K in angel funding (May 2017) plus roughly $85K in non-dilutive competition prize money, has 1–10 employees, and relies on a credentialed strategic and scientific advisory bench (former Welch Allyn CEO, former VitalConnect VP, Texas Children's Hospital CMO) to compensate for its small core team.

Short descriptiontext

Vitls is a Houston-based healthcare technology company developing an FDA 510(k)-cleared, continuous vital signs monitoring platform — the disposable Tégo wearable, Vitls Cloud, and Vitls App — that serves hospitals, pediatric patients, emergency departments, and clinical trial operators.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
continuous vital monitoring, remote patient monitoring, wearable medical devices, pediatric health monitoring, clinical-grade wearables
Industry2 codes
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Ambulatory Health Care Services621
SIC code1 code
  • Services-Home Health Care Services8082
Product category
Remote Patient Monitoring
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Wearable Device Sales
TypeHardware Sales
Description

Sale of disposable Tégo wearable devices to healthcare providers for continuous patient monitoring in hospital and home settings.

vitlsinc.com
2Cloud/SaaS Platform
TypeSubscription Recurring
Description

Subscription or usage-based access to Vitls Cloud platform for data storage, analytics, and integration with EHR systems and connected devices.

vitlsinc.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Tégo
Description

The company's flagship wearable medical device for continuous vital sign monitoring, including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement tracking.

vitlsinc.com
+1 more record
Core offering1 text field

Vitls develops a clinical-grade continuous vital signs monitoring platform consisting of the Tégo disposable wearable device, Vitls Cloud data infrastructure, and Vitls App/Dashboard. The platform enables hospitals and healthcare providers to continuously monitor patient vital signs including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement for up to 5-6 days. It integrates with hospital EHR systems and delivers real-time notifications when patient vitals deteriorate.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Deterioration can be identified and treated more than 60 percent earlier with continuous, remote monitoring
+2 more records
Product overview1 text field

Vitls offers a unified remote patient monitoring platform consisting of three integrated components: the Tégo wearable device (a small, disposable, wireless vital signs monitor worn on the chest), the Vitls Cloud (HIPAA-compliant cloud database for data storage and transmission), and the Vitls App/Dashboard (for viewing continuous vital sign data, receiving instant notifications, and accessing patient trends). The platform is designed for continuous, unobtrusive monitoring of patients in hospital and home settings, enabling early detection of patient deterioration.

Product and service5 records
1Vitls Platform
CategoryRemote Patient Monitoring
Description

Clinical-grade remote patient monitoring platform combining the Tégo wearable device, Vitls Cloud, and Vitls App for continuous vital sign data capture, storage, transmission, and review. Designed for hospital and home use.

2Tégo Wearable Device
CategoryWearable Medical Device
Description

Small, thin, flexible, waterproof, disposable wireless wearable medical device placed on the patient that continuously monitors body temperature, pulse rate, heart rate variability, respiration rate, pulse ox (SpO2), sleep, and movement for up to 5-6 days on a single battery.

3Vitls Cloud
CategoryCloud Data Platform
Description

HIPAA-compliant cloud database that ingests vital sign data from Tégo devices and transmits it to EHR systems, nurse stations, the Vitls App, and connected smart devices with real-time notifications and trend history.

4Vitls App
CategoryMobile Application
Description

Native iOS and Android mobile application that displays continuous vital sign data, delivers instant notifications, shows complete patient data trends, and allows providers to add notes.

5Vitls Dashboard
CategoryWeb Dashboard
Description

Web-based dashboard accessible via any browser providing live monitoring view, instant notifications, patient data trends, and the ability to add notes; intended for nurse stations and clinical workstations.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Accepted into KidsX, the largest pediatric-focused digital health accelerator globally. The 13-week virtual program pairs early-stage digital health companies with clinician and administrative leaders at leading pediatric hospitals to validate clinical efficacy and scale solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Participated in TMCx Medical Device Program in 2017. The program provides startups access to hospital stakeholders and key opinion leaders at the world's largest medical center.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Accepted into Dreamit Ventures' Health Program in Philadelphia. The program provides access to Dreamit's network and expertise in health technology commercialization.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Won $50,000 grant at NCC-PDI 'Make Your Medical Device Pitch for Kids!' COVID-19 edition competition. NCC-PDI is one of five members in FDA's Pediatric Device Consortia Grant Program.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Masimo is a global leader in pulse oximetry and patient monitoring with wearable products (e.g., Radius PPG, MightySat) and a connected health platform, representing a broad incumbent competing across multiple vital signs categories Vitls addresses.

TypeDirect peer
Description

iRhythm's Zio wearable cardiac monitor provides continuous ambulatory ECG monitoring with cloud-based analytics, offering a comparable model of disposable wearable plus cloud platform for remote patient monitoring.

TypeBroad incumbent
Description

GE HealthCare provides a broad portfolio of patient monitoring solutions (including wearable and continuous monitoring within its CARESCAPE and Mural offerings), positioning it as a larger incumbent that hospitals may choose over point solutions like Vitls.

4VitalConnect
TypeDirect peer
Description

VitalConnect offers the VitalPatch, a wearable biosensor for continuous multi-parameter vital sign monitoring in hospital and remote settings, directly competing with the Vitls T égo device in clinical-grade continuous monitoring use cases.

TypeDirect peer
Description

Preventice offers BodyGuardian wearable remote cardiac monitors used in hospital-to-home transitions, a comparable model of wearable biosensor plus cloud monitoring that now competes under Boston Scientific's commercial reach.

TypeEmerging player
Description

Empatica develops FDA-cleared wearable devices and a cloud platform for continuous health monitoring (including pediatric epilepsy detection), overlapping with Vitls on wearable form factor, clinical-grade monitoring, and pediatric use cases.

TypeEmerging player
Description

Medidata offers decentralized clinical trial platforms with wearable sensor integrations for remote patient monitoring during trials, directly comparable to Vitls' pharmaceutical/CRO use case for monitoring trial participants at home.

TypeDirect peer
Description

Sotera Wireless developed the ViSi Mobile wearable monitor for continuous surveillance of multiple vital signs in ambulatory hospital patients, making it a directly comparable peer in continuous wearable vital signs monitoring.

TypeDirect peer
Description

EarlySense provides contact-free continuous monitoring of heart rate, respiration, and motion for hospital and post-acute settings, competing for the same clinical use cases of detecting patient deterioration outside the ICU.

TypeBroad incumbent
Description

Philips acquired BioTelemetry to expand its remote cardiac and multi-parameter monitoring portfolio, making it a broad incumbent offering hospital and home RPM solutions that overlap with Vitls' continuous monitoring use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vitls

Remote Patient Monitoringvitlsinc.com

Vitls is a Houston-based healthcare technology company developing an FDA 510(k)-cleared, continuous vital signs monitoring platform — the disposable Tégo wearable, Vitls Cloud, and Vitls App — that serves hospitals, pediatric patients, emergency departments, and clinical trial operators.

What Vitls does

Vitls is a Houston-based healthcare technology company that develops an FDA 510(k)-cleared continuous vital signs monitoring platform for clinical and home use. Founded in 2016 by Werner Vorster after his son suffered from febrile seizures, the company relocated from South Africa to Texas to access the U.S. healthcare market and the Texas Medical Center innovation ecosystem. The platform combines a disposable, thin, flexible, waterproof wearable device (Tégo) with a 5-day battery life, a HIPAA-compliant cloud backend (Vitls Cloud), and mobile/web applications (Vitls App and Dashboard) that stream continuous vital signs — including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement/fall detection — to clinicians and EHR systems.

The company targets hospitals and healthcare systems (post-operative monitoring, general floor surveillance outside the ICU), emergency departments (rapid triage), pharmaceutical companies and CROs (remote monitoring of clinical trial participants), and pediatric patients aged two and older as a differentiated use case. Its go-to-market is direct enterprise field sales to hospitals, supplemented by channel signals through accelerator and competition programs (TMCx, Dreamit Ventures, KidsX, NCC-PDI). Pricing is quote-based and not publicly disclosed.

Vitls generates revenue through two streams: sales of disposable Tégo wearable devices (hardware) and subscription/usage-based access to the Vitls Cloud platform (recurring SaaS-style). Revenue and customer count are not disclosed; the company reports only five or more healthcare-provider pilots in Houston, Philadelphia, and New York, including an IRB-approved study with Texas Children's Hospital and a trial invitation at a 30-bed oncology unit. The company has raised approximately $100K in angel funding (May 2017) plus roughly $85K in non-dilutive competition prize money, has 1–10 employees, and relies on a credentialed strategic and scientific advisory bench (former Welch Allyn CEO, former VitalConnect VP, Texas Children's Hospital CMO) to compensate for its small core team.

Vitls firmographics

Firmographics
Name
Vitls
Legal name
Vitls Inc.
Website
https://vitlsinc.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Vitls is a Houston-based healthcare technology company developing an FDA 510(k)-cleared, continuous vital signs monitoring platform — the disposable Tégo wearable, Vitls Cloud, and Vitls App — that serves hospitals, pediatric patients, emergency departments, and clinical trial operators.
Ownership category
akta.pro rank

Vitls industry classification

Industry
Product category
Remote Patient Monitoring
NAICS
Ambulatory Health Care Services (621)
SIC
Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Continuous vital monitoring
  • Remote patient monitoring
  • Wearable medical devices
  • Pediatric health monitoring
  • Clinical-grade wearables

Where Vitls is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vitls business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Wearable Device Sales: Sale of disposable Tégo wearable devices to healthcare providers for continuous patient monitoring in hospital and home settings.
  2. Cloud/SaaS Platform: Subscription or usage-based access to Vitls Cloud platform for data storage, analytics, and integration with EHR systems and connected devices.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Vitls product offering

Product offering

Core offering

Vitls develops a clinical-grade continuous vital signs monitoring platform consisting of the Tégo disposable wearable device, Vitls Cloud data infrastructure, and Vitls App/Dashboard. The platform enables hospitals and healthcare providers to continuously monitor patient vital signs including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement for up to 5-6 days. It integrates with hospital EHR systems and delivers real-time notifications when patient vitals deteriorate.

Product overview

Vitls offers a unified remote patient monitoring platform consisting of three integrated components: the Tégo wearable device (a small, disposable, wireless vital signs monitor worn on the chest), the Vitls Cloud (HIPAA-compliant cloud database for data storage and transmission), and the Vitls App/Dashboard (for viewing continuous vital sign data, receiving instant notifications, and accessing patient trends). The platform is designed for continuous, unobtrusive monitoring of patients in hospital and home settings, enabling early detection of patient deterioration.

Differentiator

Problem solved

Functional benefit

Brands

  • Tégo: The company's flagship wearable medical device for continuous vital sign monitoring, including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement tracking.
  • Vitls Platform

Products and services

  • Vitls Platform Clinical-grade remote patient monitoring platform combining the Tégo wearable device, Vitls Cloud, and Vitls App for continuous vital sign data capture, storage, transmission, and review. Designed for hospital and home use.
  • Tégo Wearable Device Small, thin, flexible, waterproof, disposable wireless wearable medical device placed on the patient that continuously monitors body temperature, pulse rate, heart rate variability, respiration rate, pulse ox (SpO2), sleep, and movement for up to 5-6 days on a single battery.
  • Vitls Cloud HIPAA-compliant cloud database that ingests vital sign data from Tégo devices and transmits it to EHR systems, nurse stations, the Vitls App, and connected smart devices with real-time notifications and trend history.
  • Vitls App Native iOS and Android mobile application that displays continuous vital sign data, delivers instant notifications, shows complete patient data trends, and allows providers to add notes.
  • Vitls Dashboard Web-based dashboard accessible via any browser providing live monitoring view, instant notifications, patient data trends, and the ability to add notes; intended for nurse stations and clinical workstations.

Quantifiable outcome

  • Deterioration can be identified and treated more than 60 percent earlier with continuous, remote monitoring
  • +2 more outcomes

Companies that use Vitls

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Vitls technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Vitls partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • KidsX AcceleratorcoreStrategic or Co-development PartnerAccepted into KidsX, the largest pediatric-focused digital health accelerator globally. The 13-week virtual program pairs early-stage digital health companies with clinician and administrative leaders at leading pediatric hospitals to validate clinical efficacy and scale solutions.
  • Texas Medical Center Innovation Institute (TMCx)coreStrategic or Co-development PartnerParticipated in TMCx Medical Device Program in 2017. The program provides startups access to hospital stakeholders and key opinion leaders at the world's largest medical center.
  • Dreamit VenturescoreStrategic or Co-development PartnerAccepted into Dreamit Ventures' Health Program in Philadelphia. The program provides access to Dreamit's network and expertise in health technology commercialization.
  • National Capital Consortium for Pediatric Device Innovation (NCC-PDI)coreStrategic or Co-development PartnerWon $50,000 grant at NCC-PDI 'Make Your Medical Device Pitch for Kids!' COVID-19 edition competition. NCC-PDI is one of five members in FDA's Pediatric Device Consortia Grant Program.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Vitls competitors and assessment

Company assessment

Broad incumbents

  • Masimo: Masimo is a global leader in pulse oximetry and patient monitoring with wearable products (e.g., Radius PPG, MightySat) and a connected health platform, representing a broad incumbent competing across multiple vital signs categories Vitls addresses.
  • GE HealthCare: GE HealthCare provides a broad portfolio of patient monitoring solutions (including wearable and continuous monitoring within its CARESCAPE and Mural offerings), positioning it as a larger incumbent that hospitals may choose over point solutions like Vitls.
  • Philips (BioTelemetry / RPM): Philips acquired BioTelemetry to expand its remote cardiac and multi-parameter monitoring portfolio, making it a broad incumbent offering hospital and home RPM solutions that overlap with Vitls' continuous monitoring use cases.

Direct peers

  • iRhythm Technologies: iRhythm's Zio wearable cardiac monitor provides continuous ambulatory ECG monitoring with cloud-based analytics, offering a comparable model of disposable wearable plus cloud platform for remote patient monitoring.
  • VitalConnect: VitalConnect offers the VitalPatch, a wearable biosensor for continuous multi-parameter vital sign monitoring in hospital and remote settings, directly competing with the Vitls T égo device in clinical-grade continuous monitoring use cases.
  • Preventice Solutions (Boston Scientific): Preventice offers BodyGuardian wearable remote cardiac monitors used in hospital-to-home transitions, a comparable model of wearable biosensor plus cloud monitoring that now competes under Boston Scientific's commercial reach.
  • Sotera Wireless: Sotera Wireless developed the ViSi Mobile wearable monitor for continuous surveillance of multiple vital signs in ambulatory hospital patients, making it a directly comparable peer in continuous wearable vital signs monitoring.
  • EarlySense: EarlySense provides contact-free continuous monitoring of heart rate, respiration, and motion for hospital and post-acute settings, competing for the same clinical use cases of detecting patient deterioration outside the ICU.

Emerging players

  • Empatica: Empatica develops FDA-cleared wearable devices and a cloud platform for continuous health monitoring (including pediatric epilepsy detection), overlapping with Vitls on wearable form factor, clinical-grade monitoring, and pediatric use cases.
  • Medidata Solutions (Dassault Systèmes): Medidata offers decentralized clinical trial platforms with wearable sensor integrations for remote patient monitoring during trials, directly comparable to Vitls' pharmaceutical/CRO use case for monitoring trial participants at home.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Vitls social profiles

Digital presence

Vitls compliance and trust

Trust signal

Compliance2 records

Vitls financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vitls leadership team

Management profile

Number of profiles

Profiles9 records

Vitls funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vitls M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitls

What does Vitls do?

Vitls develops a clinical-grade continuous vital signs monitoring platform consisting of the Tégo disposable wearable device, Vitls Cloud data infrastructure, and Vitls App/Dashboard. The platform enables hospitals and healthcare providers to continuously monitor patient vital signs including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement for up to 5-6 days. It integrates with hospital EHR systems and delivers real-time notifications when patient vitals deteriorate.

Is Vitls a public or private company?

Vitls is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vitls founded?

Vitls was founded in 2016. It employs 1 to 10 people.

Where is Vitls based?

Vitls is headquartered in Houston, United States, in the North America region.

How does Vitls make money?

Two revenue lines are on record. Wearable Device Sales are the primary driver. The others are cloud/SaaS Platform.

Who are Vitls's main competitors?

Broad incumbents on record are Masimo, GE HealthCare and Philips (BioTelemetry / RPM). Direct peers are iRhythm Technologies, VitalConnect, Preventice Solutions (Boston Scientific), Sotera Wireless and EarlySense. Emerging players are Empatica and Medidata Solutions (Dassault Systèmes).

Does Vitls have an API?

No public API is recorded for Vitls.

What industry is Vitls in?

Vitls's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 621 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BenestudioTeleHealth startupsThe HealthTech Networking Club presents a curated list of telehealth and digital health startups, including Wellsheet, Vitls, ViTel Health, and others, highlighting their technological innovations in areas such as AI, remote monitoring, and patient engagement. The article details the specific services offered by these companies, ranging from predictive clinical workflows to veterinary advice and chronic disease management. It also provides instructions for interested parties to apply for membership in the networking club via LinkedIn.MobiHealthNewsVitls scores 510(k) clearance for continual and remote vital signs monitoring deviceVitls announced it has received 510(k) clearance from the FDA for its remote and continuous vital signs monitoring platform, which utilizes a wearable device called Tgo. This regulatory approval allows healthcare providers to monitor patient vitals in real-time via hospital systems and the Vitls app, supporting the company's planned US launch in Q3 2020. The development aligns with the growing trend of remote monitoring technologies adopted during the COVID-19 pandemic.VentureburnHere are the 8 startups that’ll be competing at Seedstars DurbanSeedstars World announced eight startups competing in its Durban leg of the South African competition, including You, Baby and I, Vitls, and Guardian Angel Safety Solution. The event takes place on 8 June at Mancosa, with the top three advancing to the Johannesburg finale.